Intervention Protocol

Celecoxib for schizophrenia

  1. Shahin Akhondzadeh,
  2. Amirhossein Modabbernia*,
  3. Shervin Taslimi,
  4. Ali Daneshmand,
  5. Mohammadreza Ostovaneh

Editorial Group: Cochrane Schizophrenia Group

Published Online: 6 JUL 2011

DOI: 10.1002/14651858.CD009205

How to Cite

Akhondzadeh S, Modabbernia A, Taslimi S, Daneshmand A, Ostovaneh M. Celecoxib for schizophrenia (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.: CD009205. DOI: 10.1002/14651858.CD009205.

Author Information

  1. Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Department of Psychiatry, Tehran, Iran

*Amirhossein Modabbernia, Department of Psychiatry, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Street,, Tehran, 13337,, Iran.

Publication History

  1. Publication Status: New
  2. Published Online: 6 JUL 2011


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.